Replicating Huntington's disease phenotype in experimental animals, Prog Neurobiol, vol.59, issue.5, pp.427-468, 1999. ,
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group, Cell, vol.72, issue.6, pp.971-983, 1993. ,
A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats, N Engl J Med, vol.330, issue.20, pp.1401-1406, 1994. ,
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset, Proc Natl Acad Sci U S A, vol.101, issue.10, pp.3498-3503, 2004. ,
Ageing and neuronal vulnerability, Nat Rev Neurosci, vol.7, issue.4, pp.278-294, 2006. ,
Aging and regulated protein degradation: who has the UPPer hand?, Aging Cell, vol.6, issue.5, pp.599-606, 2007. ,
Ca2+ regulation and gene expression in normal brain aging, Trends Neurosci, vol.27, issue.10, pp.614-620, 2004. ,
Mitochondria take center stage in aging and neurodegeneration, Ann Neurol, vol.58, issue.4, pp.495-505, 2005. ,
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease, J Neurochem, vol.95, issue.6, pp.1521-1540, 2005. ,
A one-hit model of cell death in inherited neuronal degenerations, Nature, vol.406, issue.6792, pp.195-199, 2000. ,
Lentiviralmediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length, J Neurosci, vol.22, issue.9, pp.3473-3483, 2002. ,
CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity, J Neurosci, vol.26, issue.17, pp.4649-4659, 2006. ,
Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421, J Neurosci, vol.26, issue.5, pp.1635-1645, 2006. ,
Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates, Mol Ther, vol.15, issue.8, pp.1444-1451, 2007. ,
Akt is altered in an animal model of Huntington's disease and in patients, Eur J Neurosci, vol.21, issue.6, pp.1478-1488, 2005. ,
Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology, J Neurosci, vol.19, issue.7, pp.2522-2534, 1999. ,
Huntington aggregates may not predict neuronal death in Huntington's disease, Ann Neurol, vol.46, issue.6, pp.842-849, 1999. ,
Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity, Nat Genet, vol.25, issue.4, pp.385-389, 2000. ,
Huntingtin aggregateassociated axonal degeneration is an early pathological event in Huntington's disease mice, J Neurosci, vol.21, issue.21, pp.8473-8481, 2001. ,
Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease, Hum Gene Ther, vol.13, issue.16, pp.1981-1990, 2002. ,
Changes in the structural complexity of the aged brain, Aging Cell, vol.6, issue.3, pp.275-284, 2007. ,
Regional and cellular gene expression changes in human Huntington's disease brain, Hum Mol Genet, vol.15, issue.6, pp.965-977, 2006. ,
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease, Hum Mol Genet, vol.9, issue.9, pp.1259-1271, 2000. ,
Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease, J Neurochem, vol.96, issue.3, pp.743-757, 2006. ,
Alterations of cAMP response element-binding activity in the aged rat brain in response to administration of rolipram, a cAMP-specific phosphodiesterase inhibitor, Brain Res Mol Brain Res, vol.41, issue.1-2, pp.210-215, 1996. ,
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription, Proc Natl Acad Sci U S A, vol.97, issue.12, pp.6763-6768, 2000. ,
Transcriptional abnormalities in Huntington disease, Trends Genet, vol.19, issue.5, pp.233-238, 2003. ,
Lentiviruses as vectors for CNS diseases, Curr Top Microbiol Immunol, vol.261, pp.191-209, 2002. ,
Viral vectors as tools to model and treat neurodegenerative disorders, J Gene Med, vol.7, issue.5, pp.530-539, 2005. ,
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, vol.277, issue.5334, pp.1990-1993, 1997. ,
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, vol.90, issue.3, pp.537-548, 1997. ,
Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice, Hum Mol Genet, vol.8, issue.7, pp.1227-1236, 1999. ,
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death, Nature, vol.431, issue.7010, pp.805-810, 2004. ,
Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions, Cell, vol.95, issue.1, pp.55-66, 1998. ,
HAP1 and intracellular trafficking, Trends Pharmacol Sci, vol.26, issue.1, pp.1-3, 2005. ,
A huntingtinassociated protein enriched in brain with implications for pathology, Nature, vol.378, issue.6555, pp.398-402, 1995. ,
HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain, Nat Genet, vol.16, issue.1, pp.44-53, 1997. ,
HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system, Hum Mol Genet, vol.6, issue.3, pp.487-495, 1997. ,
Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin, J Cell Biol, vol.181, issue.5, pp.803-816, 2008. ,
Modeling mitochondrial function in aging neurons, Trends Neurosci, vol.27, issue.10, pp.601-606, 2004. ,
The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations, Proc Natl Acad Sci U S A, vol.102, issue.52, pp.18769-18770, 2005. ,
Gene regulation and DNA damage in the ageing human brain, Nature, vol.429, issue.6994, pp.883-891, 2004. ,
Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain, Mol Chem Neuropathol, vol.31, issue.1, pp.53-64, 1997. ,
Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain, Ann Neurol, vol.34, issue.4, pp.609-616, 1993. ,
Oxidants, oxidative stress and the biology of ageing, Nature, vol.408, issue.6809, pp.239-247, 2000. ,
Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease, J Neurochem, vol.79, issue.6, pp.1246-1249, 2001. ,
Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease, J Neurochem, vol.71, issue.6, pp.2642-2644, 1998. ,
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease, J Neurosci, vol.22, issue.5, pp.1592-1599, 2002. ,
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice, Biochim Biophys Acta, vol.1762, issue.6, pp.616-626, 2006. ,
Oxidative damage in Huntington's disease pathogenesis, Antioxid Redox Signal, vol.8, pp.2061-2073, 2006. ,
, Cell, vol.110, issue.1, pp.9-12, 2002.
mediates cellular dysfunction and behavioral abnormalities in Huntington's disease, Neuron, vol.47, issue.1, pp.29-41, 2005. ,
Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons, Nat Genet, vol.37, issue.4, pp.349-350, 2005. ,
Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1, Nature, vol.434, issue.7029, pp.113-118, 2005. ,
Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration, Cell, vol.127, issue.1, pp.59-69, 2006. ,
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration, Cell Metab, vol.4, issue.5, pp.349-362, 2006. ,
Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the agedependent decrease in proteasome activity, J Cell Biol, vol.163, issue.1, pp.109-118, 2003. ,
Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus, J Neurosci, vol.20, issue.15, pp.5587-5593, 2000. ,
Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease, Neurobiol Dis, vol.8, issue.3, pp.433-446, 2001. ,
Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease, J Neurosci, vol.23, issue.12, pp.5020-5030, 2003. ,
Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease, Mol Ther, vol.15, issue.5, pp.903-911, 2007. ,
A consideration of neural counting methods, Trends Neurosci, vol.15, issue.1, pp.9-13, 1992. ,
Chronic alcohol consumption and withdrawal do not induce cell death in the suprachiasmatic nucleus, but lead to irreversible depression of peptide immunoreactivity and mRNA levels, J Neurosci, vol.17, issue.4, pp.1302-1319, 1997. ,
Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator, Anat Rec, vol.231, issue.4, pp.482-497, 1991. ,
The rat brain in stereotaxic coordinates, 1986. ,